Ph1b study of the PI3K inhibitor taselisib (GDC-0032) in combination with letrozole in patients with hormone receptor-positive advanced breast cancer Meeting Abstract
| Authors: | Saura, C.; Sachdev, J.; Patel, M. R.; Cervantes, A.; Juric, D.; Infante, J. R.; Richards, D.; Sanabria, S.; Lu, X. Y.; Ware, J.; Wilson, T. R.; Parmar, H.; Hsu, J. Y.; Oliveira, M.; Winer, E. P.; Von Hoff, D. D.; Baselga, J.; Krop, I. E. |
| Abstract Title: | Ph1b study of the PI3K inhibitor taselisib (GDC-0032) in combination with letrozole in patients with hormone receptor-positive advanced breast cancer |
| Meeting Title: | 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2014 Dec 9-13 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-05-01 |
| Language: | English |
| ACCESSION: | WOS:000356730200166 |
| DOI: | 10.1158/1538-7445.sabcs14-pd5-2 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD5-2 -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos |
